Michael Lee Ryan - 03 Jun 2024 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Director
Signature
/s/ Bryan McMichael, as Attorney-in-Fact for Michael Lee Ryan
Issuer symbol
CHRS
Transactions as of
03 Jun 2024
Net transactions value
$0
Form type
4
Filing time
05 Jun 2024, 18:51:30 UTC
Previous filing
20 Jul 2023
Next filing
13 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHRS Stock Option (Right to Buy) Award $0 +112,000 $0.000000 112,000 03 Jun 2024 Common Stock 112,000 $1.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date.